Shi‐Long Lu
Impact in
- Cancer Research top 2%
- Oncology top 2%
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
Papers in
-
- TGF-β signaling in diseases 13
- Hedgehog Signaling Pathway Studies 4
- Oncology 19
- Pancreatic and Hepatic Oncology Research 4
- Cancer Cells and Metastasis 3
- Co-authors
- Xiao‐Jing Wang (15 shared papers)Allen G. Li (4 shared papers)Douglas D. Reh (3 shared papers)Yoshimitsu Akiyama (4 shared papers)Gangwen Han (4 shared papers)Christopher L. Corless (2 shared papers)Sanford D. Markowitz (3 shared papers)Dawn Dawson (3 shared papers)
- Journals
- Cancer Research (4 papers)Molecular Carcinogenesis (3 papers)Biochemical and Biophysical Research Communications (3 papers)Clinical Cancer Research (2 papers)Osteoarthritis and Cartilage (2 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Shi‐Long Lu
63 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Cancer Research 669
- Oncology 1.1k
- Pathology and Forensic Medicine 529
- Molecular Biology 1.8k
- Otorhinolaryngology 89
Countries citing papers authored by Shi‐Long Lu
This map shows the geographic impact of Shi‐Long Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi‐Long Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi‐Long Lu more than expected).
Fields of papers citing papers by Shi‐Long Lu
This network shows the impact of papers produced by Shi‐Long Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi‐Long Lu. The network helps show where Shi‐Long Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Shi‐Long Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CIP2A Inhibits PP2A in Human Malignancies Hit paper breakdown → | 2007 | 533 |
| 2 | 2005 | 283 | |
| 3 | 2004 | 196 | |
| 4 | 2009 | 171 | |
| 5 | 2004 | 168 | |
| 6 | 2006 | 165 | |
| 7 | 2011 | 134 | |
| 8 | 2006 | 129 | |
| 9 | 2019 | 94 | |
| 10 | 2015 | 91 | |
| 11 | 1995 | 87 | |
| 12 | Genomic structure of the transforming growth factor beta type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers. | 1996 | 81 |
| 13 | PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer. | 2003 | 76 |
| 14 | 2011 | 71 | |
| 15 | 2004 | 66 | |
| 16 | 2012 | 65 | |
| 17 | 2016 | 58 | |
| 18 | 2012 | 52 | |
| 19 | 2022 | 50 | |
| 20 | 2006 | 47 |
About Shi‐Long Lu
Shi‐Long Lu is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Cancer Research and Surgery, having authored 63 papers that have together received 3.3k indexed citations. Recurring topics across this work include TGF-β signaling in diseases (13 papers), Genetic factors in colorectal cancer (7 papers), NF-κB Signaling Pathways (5 papers), Hedgehog Signaling Pathway Studies (4 papers), Cancer-related molecular mechanisms research (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Cancer Cells and Metastasis (3 papers) and Salivary Gland Tumors Diagnosis and Treatment (3 papers). The work is most often cited by research in Cancer Research (669 citations), Oncology (1.1k citations), Pathology and Forensic Medicine (529 citations), Molecular Biology (1.8k citations) and Otorhinolaryngology (89 citations). Shi‐Long Lu has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Xiao‐Jing Wang, Allen G. Li, Douglas D. Reh, Yoshimitsu Akiyama, Gangwen Han, Christopher L. Corless, Sanford D. Markowitz, Dawn Dawson, Petra Platzer and Joseph Willis. Their work appears in journals such as Cancer Research, Molecular Carcinogenesis, Biochemical and Biophysical Research Communications, Clinical Cancer Research and Osteoarthritis and Cartilage.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.